And it depends on you how soon it will be developed
Pharm Exec's latest annual listing of the top biopharma players paints a stable picture of performance for the usual placeholders, but change and disruption to current business models could upend positioning in the years ahead.
Milestone on Bayer’s path to completing the planned acquisition of Monsanto
Killing cancer cells indirectly by powering up fat cells in the bone marrow could help acute myeloid leukemia patients, according to a new study from McMaster University.
“How many different cell types are there in the human body? And how do these differences develop? Nobody really knows,” says Professor Stein Aerts from KU Leuven/VIB. But thanks to a new method developed by his team, that may be about to change.